You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

60 search results for: quality of life

Skin Dyspigmentation In Prurigo Nodularis (PN)
interactivity

Skin Dyspigmentation In Prurigo Nodularis (PN)

Dermatology
This infographic illustrates the clinical manifestations, pathophysiology and impact on patients of skin dyspigmentation in Prurigo Nodularis.
View more
IRS-ISIAN 2024 | Remission in CRSwNP: A Real-World Perspective
expert video

IRS-ISIAN 2024 | Remission in CRSwNP: A Real-World Perspective

Rhinology
Prof. Eugenio De Corso describes the importance of real-world evidence for understanding the prospects of remission and the emerging evidence of biologic effectiveness for patients with CRSwNP.
View more
Targeting Type 2 Inflammation in Children with AD​
expert video

Targeting Type 2 Inflammation in Children with AD​

Dermatology
The impact of type 2 inflammation in itch and barrier dysfunction in atopic dermatitis – Presentation from the ADVENT symposium at EAACI 2023.
View more
Asthma White Board Video
videoanimation

Asthma White Board Video

Pulmonology
Learn about type 2 inflammation in asthma, and the burden of asthma on patients and their families.
View more
Atopic Dermatitis Leads to Sleep Disruption for Children and Their Caregivers
expert video

Atopic Dermatitis Leads to Sleep Disruption for Children and Their Caregivers

Dermatology
Explore the impact of moderate-to-severe atopic dermatitis on sleep in pediatric patients – a short soundbite from EADV 2022.
View more
Clinical Remission as a Goal in Asthma Clinical Practice
expert video

Clinical Remission as a Goal in Asthma Clinical Practice

Pulmonology
Profs. Alberto Papi and Ian Pavord discuss clinical remission as a goal in asthma clinical practice beyond symptom control
View more
The Potential Long-term Consequences in AD in Children: Cardiovascular Risk, Bone Health, and Mental Health
expert video

The Potential Long-term Consequences in AD in Children: Cardiovascular Risk, Bone Health, and Mental Health

Dermatology
Dr. Marlies de Graaf highlights the potential long-term consequences of AD in children.
View more
Targeted Therapies for Children With Atopic Dermatitis - Expert Interview
expert video

Targeted Therapies for Children With Atopic Dermatitis - Expert Interview

Dermatology
Dermatologist Elaine Seigfried discusses burden & therapeutic landscape of pediatric atopic dermatitis
View more
Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children
expert video

Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children

Dermatology
Explore WCD 2023 ADVENT symposium's insights into managing short and long-term challenges of pediatric atopic dermatitis.
View more
Targeting Type 2 Inflammation in Children with Atopic Dermatitis: Opportunity for Early Intervention? - Q&As
expert video

Targeting Type 2 Inflammation in Children with Atopic Dermatitis: Opportunity for Early Intervention? - Q&As

Dermatology
Clinical trial and real-world data for targeted therapies for children with atopic dermatitis– Presentation from the ADVENT symposium at EAACI 2023.
View more
Exploring Neurosensitization and Pain in Prurigo Nodularis
expert video

Exploring Neurosensitization and Pain in Prurigo Nodularis

Dermatology
Dr. Gil Yosipovitch explains that patients with PN may experience pain due to neurosensitization.
View more
How Should We Define and Classify Prurigo Nodularis?
expert video

How Should We Define and Classify Prurigo Nodularis?

Dermatology
Dr. Sarina Elmariah explains how to recognize and classify PN, using clinical examples and comparisons with related conditions. She then discusses PN assessment in clinical studies and practice, and the unmet needs in disease understanding and diagnosis.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: IsraelChange country/region